Prab: CSV import

2025-03-23T18:59:20Z

CSV import

← Older revision		Revision as of 18:59, 23 March 2025
Line 1:		Line 1:
	~~'''Biocon''' is a [[~~biopharmaceutical]] company based in [[Bangalore]], [[India]]. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics, as well as, biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.		{{short description\|Indian biopharmaceutical company}}
			{{Use dmy dates\|date=October 2023}}

	~~== History ==~~		[[File:Biocon_Logo.svg\|thumb\|right\|Biocon Logo]]

	Biocon ~~was established~~ in 1978 by [[Kiran Mazumdar-Shaw]], ~~who started the company in the garage of her rented house in Bangalore. It was initially a joint venture with~~ Biocon ~~Biochemicals Limited,~~ of ~~Cork, Ireland. In 1989,~~ the ~~collaboration with Biocon Biochemicals was restructured into a separate company. Today~~, ~~Biocon is among~~ the ~~top 20 global biotechnology companies~~ and ~~the largest publicly traded biopharmaceutical company in Asia~~.		'''Biocon Limited''' is an Indian biopharmaceutical company based in [[Bangalore]], [[India]]. Founded in 1978 by [[Kiran Mazumdar-Shaw]], Biocon has grown to become one of the leading biotechnology companies in India, focusing on the development of innovative and affordable biopharmaceuticals.

	== ~~Products and Services~~ ==		==History==
			Biocon was established in 1978 as a joint venture between Kiran Mazumdar-Shaw and an Irish firm, Biocon Biochemicals Limited. Initially, the company focused on the production of enzymes for the brewing industry. Over the years, Biocon expanded its operations to include the development of biopharmaceuticals, with a focus on [[diabetes]], [[oncology]], and [[autoimmune diseases]].

	Biocon~~'s product portfolio includes a range of [[biopharmaceuticals]]~~, including ~~[[monoclonal antibodies]]~~, ~~[[biosimilars]], [[immunosuppressants]]~~, and ~~[[vaccines]]~~. The company~~'s products are used~~ in the ~~treatment~~ of a ~~variety~~ of ~~diseases~~, including [[~~cancer]], [[diabetes~~]], [[~~autoimmune diseases~~]], and [[~~infectious diseases~~]].		==Operations==
			Biocon operates through its various subsidiaries and divisions, including Biocon Biologics, Syngene International, and Clinigene International. The company is involved in the research, development, and manufacturing of a wide range of products, including [[biosimilars]], [[novel biologics]], and [[generic drugs]].

	Biocon~~'s services include [[contract research]]~~, ~~[[clinical~~ development~~]],~~ and ~~[[contract manufacturing]]~~. The company ~~also provides support~~ in the ~~areas of [[regulatory affairs]]~~, ~~[[quality assurance]], and [[project management]]~~.		===Biocon Biologics===
			Biocon Biologics is a subsidiary of Biocon Limited, focusing on the development and commercialization of biosimilars. The company has a strong presence in the global biosimilars market, with products approved in over 100 countries.

	== ~~Research and Development~~ ==		===Syngene International===
			[[File:Bangalore_Biocon.jpg\|thumb\|left\|Biocon's headquarters in Bangalore]]
			Syngene International is a contract research organization (CRO) that provides integrated research and development services to global pharmaceutical and biotechnology companies. It offers services in discovery chemistry, discovery biology, and clinical development.

	~~Biocon's [[~~research ~~and development]]~~ (~~R&D~~) ~~efforts are focused~~ on ~~developing innovative and affordable biopharmaceuticals~~ for ~~diseases that are prevalent in India~~ and ~~other emerging markets. The company's R&D team is involved in the entire drug development process~~, ~~from discovery to clinical development~~.		===Clinigene International===
			Clinigene International is a clinical research organization (CRO) that provides clinical trial management services. It focuses on conducting clinical trials for new drugs and therapies, ensuring compliance with international regulatory standards.

	== ~~See Also~~ ==		==Research and Development==
			Biocon invests significantly in research and development to drive innovation in biopharmaceuticals. The company's R&D efforts are focused on developing novel biologics and biosimilars for the treatment of chronic diseases such as diabetes, cancer, and autoimmune disorders.

	* [[~~Biopharmaceutical~~]]		==Biocon Park==
	* [[Biosimilar]]		[[File:Biocon_Park_.jpg\|thumb\|right\|Biocon Park]]
	* [[Monoclonal antibodies]]		Biocon Park is a state-of-the-art integrated research and manufacturing facility located in Bangalore. It is one of the largest biopharmaceutical manufacturing facilities in India, equipped with advanced technology and infrastructure to support the production of biologics and biosimilars.
	* [[Kiran Mazumdar-Shaw]]
			==Corporate Social Responsibility==
			Biocon is committed to corporate social responsibility (CSR) initiatives, focusing on healthcare, education, and environmental sustainability. The Biocon Foundation, the company's CSR arm, implements various programs aimed at improving healthcare access and quality in underserved communities.

	== ~~References~~ ==		==Awards and Recognition==
			Biocon has received numerous awards and accolades for its contributions to the biotechnology industry. The company has been recognized for its innovation, leadership, and commitment to social responsibility.

	~~<references />~~		==Related pages==
			* [[Kiran Mazumdar-Shaw]]
			* [[Biotechnology in India]]
			* [[Pharmaceutical industry in India]]

	[[Category:~~Pharmaceutical companies of India]]~~		[[Category:Biopharmaceutical companies of India]]
	~~[[Category:Biotechnology~~ companies of India]]
	[[Category:Companies based in Bangalore]]		[[Category:Companies based in Bangalore]]
	[[Category:Companies ~~listed on the Bombay Stock Exchange~~]]		[[Category:Companies established in 1978]]
	[[Category:~~Companies listed on the National Stock Exchange of India~~]]		[[Category:Indian brands]]

	~~{{medicine-stub}}~~
	~~<gallery>~~
	~~File:Biocon Logo.svg\|Biocon Logo~~
	~~File:Bangalore Biocon.jpg\|Bangalore Biocon~~
	~~File:STR 6036.jpg\|Biocon~~
	~~File:Biocon Park .jpg\|Biocon Park~~
	~~</gallery>~~
	~~<gallery>~~
	~~File:Biocon Logo.svg\|Biocon Logo~~
	~~File:Bangalore Biocon.jpg\|Biocon Bangalore~~
	~~</gallery>~~

Prab: CSV import

2025-02-20T00:49:32Z

CSV import

← Older revision		Revision as of 00:49, 20 February 2025
Line 38:		Line 38:
	File:STR 6036.jpg\|Biocon		File:STR 6036.jpg\|Biocon
	File:Biocon Park .jpg\|Biocon Park		File:Biocon Park .jpg\|Biocon Park
			</gallery>
			<gallery>
			File:Biocon Logo.svg\|Biocon Logo
			File:Bangalore Biocon.jpg\|Biocon Bangalore
	</gallery>		</gallery>

Prab: CSV import

2025-02-20T00:47:40Z

CSV import

← Older revision		Revision as of 00:47, 20 February 2025
Line 33:		Line 33:

	{{medicine-stub}}		{{medicine-stub}}
			<gallery>
			File:Biocon Logo.svg\|Biocon Logo
			File:Bangalore Biocon.jpg\|Bangalore Biocon
			File:STR 6036.jpg\|Biocon
			File:Biocon Park .jpg\|Biocon Park
			</gallery>

Prab: CSV import

2024-03-10T19:56:00Z

CSV import

New page

'''Biocon''' is a [[biopharmaceutical]] company based in [[Bangalore]], [[India]]. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics, as well as, biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

== History ==

Biocon was established in 1978 by [[Kiran Mazumdar-Shaw]], who started the company in the garage of her rented house in Bangalore. It was initially a joint venture with Biocon Biochemicals Limited, of Cork, Ireland. In 1989, the collaboration with Biocon Biochemicals was restructured into a separate company. Today, Biocon is among the top 20 global biotechnology companies and the largest publicly traded biopharmaceutical company in Asia.

== Products and Services ==

Biocon's product portfolio includes a range of [[biopharmaceuticals]], including [[monoclonal antibodies]], [[biosimilars]], [[immunosuppressants]], and [[vaccines]]. The company's products are used in the treatment of a variety of diseases, including [[cancer]], [[diabetes]], [[autoimmune diseases]], and [[infectious diseases]].

Biocon's services include [[contract research]], [[clinical development]], and [[contract manufacturing]]. The company also provides support in the areas of [[regulatory affairs]], [[quality assurance]], and [[project management]].

== Research and Development ==

Biocon's [[research and development]] (R&D) efforts are focused on developing innovative and affordable biopharmaceuticals for diseases that are prevalent in India and other emerging markets. The company's R&D team is involved in the entire drug development process, from discovery to clinical development.

== See Also ==

* [[Biopharmaceutical]]
* [[Biosimilar]]
* [[Monoclonal antibodies]]
* [[Kiran Mazumdar-Shaw]]

== References ==

<references />

[[Category:Pharmaceutical companies of India]]
[[Category:Biotechnology companies of India]]
[[Category:Companies based in Bangalore]]
[[Category:Companies listed on the Bombay Stock Exchange]]
[[Category:Companies listed on the National Stock Exchange of India]]

{{medicine-stub}}

Biocon - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import

Prab: CSV import